Suppr超能文献

[洋地黄、利尿剂及血管扩张剂治疗扩张型心肌病]

[Therapy of dilated cardiomyopathy with digitalis, diuretics and vasodilators].

作者信息

Liebau G

出版信息

Herz. 1985 Jun;10(3):138-42.

PMID:2991095
Abstract

The treatment of dilated cardiomyopathy is primarily concerned with that of congestive heart failure. Digitalis is widely use in dilated cardiomyopathy but an improvement in the prognosis has not yet been demonstrated. Furthermore, the effects of digitalis in patients with sinus rhythm are debatable. If dilated cardiomyopathy induces atrial fibrillation and tachyarrhythmia, digitalis should be used. Diuretics are helpful in the treatment of congestive heart failure associated with dilated cardiomyopathy. By reducing hypervolemia and by venous dilatation, diuretics lower preload and afterload. This leads to relief of congestion and termination of the vicious cycle of congestive heart failure. Accordingly, the prognosis of dilated cardiomyopathy might be improved by diuretics. There are numerous diuretics acting differently on the renal tubules, the choice of which depends on the renal function and serum electrolyte concentrations. Reduction of preload and afterload improves congestive heart failure as has been demonstrated repeatedly. Many substances have therefore been used for arterial and venous dilation with differing results. At least for short-term periods, congestion is reduced and cardiac output increases. Especially inhibitors of angiotensin II converting enzyme are very effective since they act both in the arterial and venous systems. Additionally, inhibition of the action of angiotensin may be regarded as causal therapy since the renin-angiotensin system is the trigger for vasoconstriction and fluid retention in congestive heart failure. Unlike other substances, ACE inhibitors have been demonstrated to improve prognosis of patients with congestive heart failure. At present, combined diuretic therapy and angiotensin conversion enzyme inhibition would seem the most reasonable treatment for patients with dilated cardiomyopathy and sinus rhythm. If atrial fibrillation and tachyarrhythmia develop, additional digitalis therapy is effective.

摘要

扩张型心肌病的治疗主要涉及充血性心力衰竭的治疗。洋地黄在扩张型心肌病中广泛使用,但尚未证明其能改善预后。此外,洋地黄对窦性心律患者的疗效存在争议。如果扩张型心肌病诱发房颤和快速心律失常,则应使用洋地黄。利尿剂有助于治疗与扩张型心肌病相关的充血性心力衰竭。通过减少血容量过多和静脉扩张,利尿剂可降低前负荷和后负荷。这会减轻充血并终止充血性心力衰竭的恶性循环。因此,利尿剂可能会改善扩张型心肌病的预后。有许多利尿剂对肾小管的作用不同,其选择取决于肾功能和血清电解质浓度。如反复证明的那样,降低前负荷和后负荷可改善充血性心力衰竭。因此,许多物质已被用于动脉和静脉扩张,但结果各异。至少在短期内,充血减轻,心输出量增加。特别是血管紧张素II转换酶抑制剂非常有效,因为它们在动脉和静脉系统中均起作用。此外,抑制血管紧张素的作用可被视为病因治疗,因为肾素-血管紧张素系统是充血性心力衰竭中血管收缩和液体潴留的触发因素。与其他物质不同,血管紧张素转换酶抑制剂已被证明可改善充血性心力衰竭患者的预后。目前,联合利尿剂治疗和血管紧张素转换酶抑制似乎是扩张型心肌病窦性心律患者最合理的治疗方法。如果发生房颤和快速心律失常,额外的洋地黄治疗有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验